ERBB2 and breast neoplasm: In recent years, radionuclide molecular imaging based on scaffold proteins has demonstrated its effectiveness as a relatively simple, non-invasive, sensitive and specific imaging method for the detection of expression of another therapeutic molecular target, HER2, in primary breast tumors and metastasis [23,24].